JW (Cayman) Therapeutics Temettü
Temettü kriter kontrolleri 0/6
JW (Cayman) Therapeutics does not have a record of paying a dividend.
Anahtar bilgiler
n/a
Temettü verimi
-0.05%
Geri Alım Getirisi
| Toplam Hissedar Getirisi | -0.05% |
| Gelecekteki Temettü Verimi | 0% |
| Temettü Büyümesi | n/a |
| Bir sonraki temettü ödeme tarihi | n/a |
| Eski temettü tarihi | n/a |
| Hisse başına temettü | n/a |
| Ödeme oranı | n/a |
Son temettü güncellemeleri
Güncelleme yok
Recent updates
JW (Cayman) Therapeutics Co. Ltd (HKG:2126) Screens Well But There Might Be A Catch
Sep 25
A Piece Of The Puzzle Missing From JW (Cayman) Therapeutics Co. Ltd's (HKG:2126) 34% Share Price Climb
May 10Calculating The Intrinsic Value Of JW (Cayman) Therapeutics Co. Ltd (HKG:2126)
May 03JW (Cayman) Therapeutics Co. Ltd (HKG:2126): When Will It Breakeven?
Feb 03Ödemelerde İstikrar ve Büyüme
Temettü verilerini getirme
İstikrarlı Temettü: Insufficient data to determine if 2126's dividends per share have been stable in the past.
Büyüyen Temettü: Insufficient data to determine if 2126's dividend payments have been increasing.
Piyasaya Karşı Temettü Getirisi
| JW (Cayman) Therapeutics Piyasaya Karşı Temettü Getirisi |
|---|
| Segment | Temettü Verimi |
|---|---|
| Şirket (2126) | n/a |
| Pazarın Alt %25'i (HK) | 3.2% |
| Pazarın En İyi %25'i (HK) | 7.9% |
| Sektör Ortalaması (Biotechs) | 1.1% |
| Analist tahmini (2126) (3 yıla kadar) | 0% |
Önemli Temettü: Unable to evaluate 2126's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.
Yüksek Temettü: Unable to evaluate 2126's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.
Hissedarlara Ödenen Kazanç
Kazanç Kapsamı: Insufficient data to calculate 2126's payout ratio to determine if its dividend payments are covered by earnings.
Hissedarlara Nakit Ödeme
Nakit Akışı Kapsamı: Unable to calculate sustainability of dividends as 2126 has not reported any payouts.